Demand Forecast
Drill-down by category, sub-category, or SKU (p50 + p95 model)
SKU · AC28F6911180824172
Magnésium bisglycinate 360 mg - 60 gélules hallal
hero
3P
COMPLEMENTS ALIMENTAIRES - THE INFUSION
Last 4 weeks demand
70
▼ 6.7% vs prev 4w
Offer Stock
928
Σ Stock across 1 live offer (1P + 3P) · 2026-10-02
1P stock
0
no 1P (MARJANEMALL) stock in the 2026-10-02 snapshot
Unit price
MAD 69
avg of last 30 sells · latest 2026-09-29
AC28F6911180824172
History (last 52 weeks) and LightGBM p95-quantile forecast for the SKU.
Cutoff: 2026-09-28 · Total forecast: 1327 units.
Actual
Realistic forecast (p50)
Optimistic
Out of stock
Price history
Weekly qty-weighted average (MAD) of every non-null price/cost column in the OrderBook for this SKU. Click a legend entry to hide/show a line.
Why this forecast?
Magnésium bisglycinate 360 mg - 60 gélules hallal · in the hero cohort · last 4 weeks 70 units, trending down -6.7% · on-hand 940 units
Signals the model saw
- Cohort: hero (308 days of history, — units sold over 52 weeks)
- Volatility (CV): 0.65 — moderate
- Recent trend: last 4w = 70 units · prev 4w = 75 units
- Stockouts (last 13 weeks): none — history is reliable
- Calendar events firing in forecast window: none
Model output
| Realistic forecast — next week | 2.5 units |
| Realistic forecast — next 4 weeks | 14.3 units |
| Realistic forecast — next 3 months | 433.1 units |
| Planning level (p75) — next 4 weeks the order-sizing basis; demand exceeds it ~1 week in 4 | 32.5 units |
| Optimistic — next week | 23.6 units |
| Optimistic — next 4 weeks (reorder target) | 135.9 units |
| Optimistic — next 3 months (quarterly PO target) | 1326.6 units |
| Legacy μ/wk (reorder pipeline) | 18.6 |
| Revenue exposure — optimistic, 3 months | MAD 92.0K |